This study showed that patients with active IBD are characterized by elevated levels of standard inflammatory markers (including CRP and calprotectin), reduced albumin levels, and a higher prevalence of fluctuations in body weight, including both weight loss and excess weight gain, compared with patients with inactive IBD. The gene discussed is ALB; the disease is irritable bowel syndrome.